Biotech
Incyte
Incyte raises $25B Public at $28B valuation
$25B
Total Raised
Public
Latest Round
1991
Founded
2500+
Employees
1801 Augustine Cut-Off, Wilmington, DE 19803
1 min read
Quick Facts
Valuation
$28B
Latest Round Size
$25B
Latest Round Date
January 2024
Incyte: Public Funding Round
Incyte has successfully raised $25B in Public funding, reaching a valuation of $28B.
Company Overview
Biopharmaceutical company
Funding Details
The Public round was led by Public.
Company Information
- Headquarters: 1801 Augustine Cut-Off, Wilmington, DE 19803
- Founded: 1991
- Employees: 2500+
- Category: Biotech
Investment
Incyte plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Public: Verified investor in Public
Key Investors
Public
Lead Investor
Verified investor in Public
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Torl Biotherapeutics
Torl Biotherapeutics raises $96M Series C at $500M valuation
Torl Biotherapeutics raises $96M in Series C at $500M valuation. Antibody-based immunotherapies for cancer patients...
Editorial Team
Oct 10, 2025
1 min read•$96M
Biotech
Nilo Therapeutics
Nilo Therapeutics raises $101M Series A at $450M valuation
Nilo Therapeutics raises $101M in Series A at $450M valuation. Developing therapies based on neuro-immunology research...
Editorial Team
Oct 9, 2025
1 min read•$101M
Biotech
Arthrosi Therapeutics
Arthrosi Therapeutics raises $153M Series E at $800M valuation
Arthrosi Therapeutics raises $153M in Series E at $800M valuation. Developing next-generation gout treatment drug for chronic conditions...
Editorial Team
Oct 8, 2025
1 min read•$153M